Connect with us
Image via AP.

Headlines

Tampa General to be one of first Florida hospitals to receive COVID-19 vaccine

The hospital could receive a shipment as early as next month.

Tampa General Hospital will be one of the first Florida hospitals to receive a shipment of the COVID-19 vaccine, a spokesperson confirmed to Florida Politics Thursday.

The bay area hospital will be one of five hospitals throughout the state to begin receiving shipments next month.

TGH in collaboration with the University of South Florida was chosen because of their involvement in the pandemic, having hosted the White House Task Force, said Dr. Seetha Lakshmi, in a news release.

“We have learned a lot in this process, and that has put us in a unique position to be able to respond in all angles of this pandemic,” Lakshmi said. “So, it was no surprise being one of the major medical centers that was chosen for vaccine delivery.”

Lakshmi said the vaccine is expected to arrive in a few weeks, although an exact date is not yet clear.

While the spokesperson could not yet confirm the other hospitals expecting the vaccine, the South Florida Sun Sentinel reported they will include AdventHealth Orlando, UF Health Jacksonville, Memorial Regional Hospital in Hollywood and Jackson Memorial Hospital in Miami.

This news comes following TGH’s administration of the first monoclonal antibody treatment to a COVID-19 patient Thursday, marking a new improvement to virus care in this pandemic.

The monoclonal bamlanivimab from Eli Lilly is a single dose treatment provided on an outpatient basis to COVID-19 patients with mild to moderate symptoms to keep patients from further deteriorating and likely avoid hospitalization.

The treatment is an hour-long infusion. After the treatment, patients are monitored for another hour for side effects and released for home care.

Production is still ramping up on the treatment, meaning there is still a limited supply of the antibodies, and it’s possible, at this point, that not all patients who qualify for the treatment will be able to receive it. Because of that, the treatment is currently being prioritized for high-risk patients.

Those include patients 65 or older, currently receiving immunosuppressive treatment, diabetic patients, obese individuals, or chronic kidney disease. Qualifying patients must also be within 10 days of symptom onset.

The U.S. Food and Drug Administration recently approved the antibodies under an Emergency Use Authorization to treat mild to moderate symptoms from COVID-19. TGH received some of the country’s first supplies and can request additional doses weekly to serve the community.

Written By

Kelly Hayes studied journalism and political science at the University of Florida. Kelly was born and raised in Tampa Bay. A recent graduate, she enjoys government and legal reporting. She has experience covering the Florida Legislature as well as local government, and is a proud Alligator alum. You can reach Kelly at kelly@floridapolitics.com.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Sign up for Sunburn

Receive our team's agenda-setting morning read of what's hot in Florida politics. Delivered straight to your inbox Monday through Friday.

Florida Politics is a statewide, new media platform covering campaigns, elections, government, policy, and lobbying in Florida. This platform and all of its content are owned by Extensive Enterprises Media.

Publisher: Peter Schorsch

Contributors & reporters: Phil Ammann, Drew Dixon, Renzo Downey, Rick Flagg, A.G. Gancarski, Joe Henderson, Janelle Irwin, Ryan Nicol, Jacob Ogles, Scott Powers, Bob Sparks, Andrew Wilson, and Kelly Hayes.
Email: Peter@FloridaPolitics.com
Phone: (727) 642-3162
Address: 204 37th Avenue North #182
St. Petersburg, Florida 33704

Connect
Sign up for Sunburn

Receive our team's agenda-setting morning read of what's hot in Florida politics. Delivered straight to your inbox Monday through Friday.